
Wockhardt (WOCKPHARMA) Share Price Falls 2.63% Today as Market Cap Stands at Rs 36,827.23 Cr
Updated: 28 Sept 2026 • 9:30 am
Posted by:

Wockhardt Share Price came under pressure in today’s trade, with Wockhardt ending at Rs 2,206.90, down 2.63% from the previous close of Rs 2,266.40. The move took the company’s market capitalisation to Rs 36,827.23 Cr, placing it in the Large Cap category. In the first part of the session, the stock opened at Rs 2,261.55 and matched that level as the day’s high before slipping to the day’s low of Rs 2,206.90. The data confirms a same-day price fall, but it does not establish a company-specific catalyst. For readers tracking Wockhardt Share Price Today, the focus now shifts to the verified price action, valuation, sector comparison and company fundamentals that sit behind Wockhardt Stock News and Wockhardt Share Price News.
The stock’s Rs 59.50 decline gives today’s move clear visibility in the market. At the same time, the available data also shows a turnover of Rs 0.99 Cr, which is a factual traded-value figure and should be read as part of the day’s record rather than as an explanation for the move. For investors searching Wockhardt Stock Falling Today or Wockhardt Share Price Fall, the essential point is simple: the share price fell, the closing level was below the previous close, and the day’s range was narrow around the opening level before the final leg lower.
Wockhardt (WOCKPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,206.9 |
| Previous Close | Rs 2,266.4 |
| Today's Move | -Rs 59.50 (-2.63%) |
| Open | Rs 2,261.55 |
| High | Rs 2,261.55 |
| Low | Rs 2,206.9 |
| Turnover | Rs 0.99 crore |
| Market Capitalisation | Rs 36,827.23 crore |
| Market Cap Category | Large Cap |
Wockhardt Share Price Today moved from an opening level of Rs 2,261.55 to a close at Rs 2,206.90, with the session high also at Rs 2,261.55 and the low at Rs 2,206.90. The previous close was Rs 2,266.40, so the stock ended Rs 59.50 lower, equal to a decline of 2.63%. That sequence shows that the share did not trade above the opening level after the first print, and the full day’s movement remained within a relatively tight band. The turnover was Rs 0.99 Cr, which is the exact traded-value metric supplied for the session. Because the event is a same-day fall, the chart of Wockhardt Share Price is best read as a snapshot of one trading day, not as a broader trend story. In that context,Wockhardt Share Price Update today is defined by the close below the previous close, the unchanged session high versus open, and the day’s low at the final closing level.
For readers following Wockhardt Share Price Today, the day’s action is important because it shows where the stock settled after testing the session floor at the close itself. The Large Cap label adds company-size context only; it does not explain the move. What it does is place Wockhardt among larger listed companies in the Indian market, which helps frame the day’s price action alongside its market capitalisation of Rs 36,827.23 Cr. The supplied data confirms a visible decline in Wockhardt Share Price, but it does not identify a fresh company event behind it. That makes the next review point the stock’s financial position and relative valuation.
Wockhardt (WOCKPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 36,827.23 crore |
| P/E Ratio | 90.04x |
| P/B Ratio | 7.32x |
| ROE | 4.29% |
| ROCE | 6.79% |
| EPS | Rs 25.17 |
| Book Value Per Share | Rs 309.81 |
| Dividend Yield | 0% |
Wockhardt carries a market capitalisation of Rs 36,827.23 Cr, with a P/E ratio of 90.04 and a P/B ratio of 7.32. On the earnings side, EPS stands at Rs 25.17, while book value is Rs 309.81 per share. The dividend yield is 0, which means the supplied historical payout metric is nil. These figures matter because they show how the market is pricing the company versus its reported earnings and balance-sheet value. The same data also shows ROE of 4.29% and ROCE of 6.79%, both of which are modest relative to the higher valuation multiple. That combination is central to any Wockhardt Fundamental Analysis view.
For Wockhardt Share Price, the fundamental picture is therefore not just about today’s decline. It is also about whether the current valuation leaves room for the market to justify the stock’s pricing through future earnings or capital returns. The company’s EPS and book value provide a useful starting point for that assessment, while ROE and ROCE help show how efficiently capital has been used in the most recent reported numbers. In a stock such as Wockhardt,Wockhardt Stock Analysis naturally depends on reading today’s price move alongside these exact fundamentals rather than isolating the fall on its own. That context is especially relevant for readers scanning Wockhardt Financial Results and Wockhardt Latest News together.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 90.04x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 49.63x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 7.32x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.33x |
| Company ROE | 4.29% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10.04% |
| Company ROCE | 6.79% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.82% |
| Company Market Capitalisation | Rs 36,827.23 crore |
| Benchmark Median Market Cap | Rs 732.57 crore |
| Benchmark Average Market Cap | Rs 14,043.26 crore |
Wockhardt operates in Healthcare, within the Pharmaceuticals & Drugs industry, where the supplied benchmark set covers 204 companies from the same industry. In that benchmark scope, Wockhardt’s P/E of 90.04 is above the industry median of 32.87 and above the average of 49.63. Its P/B of 7.32 is also above the median of 2.85 and above the average of 4.33. On profitability, ROE of 4.29% is below the industry median of 11.48% and below the average of 10.04%, while ROCE of 6.79% is below the median of 13.17% and below the average of 12.82%. These are direct comparisons from the same industry benchmark and are central to sector reading for Wockhardt Share Price.
The benchmark company-count data also helps place Wockhardt’s Rs 36,827.23 Cr market capitalisation in context: the industry median market cap is Rs 732.57 Cr, while the average is Rs 14,043.26 Cr. Within that frame, Wockhardt sits well above the median and average size markers for the same industry. Sector context is therefore mixed: the stock is larger than many peers by market capitalisation, yet its valuation multiples are also materially higher than the benchmark central tendency. That combination is important for those following Wockhardt Share Price Today, because today’s move occurred against a backdrop of an already premium-looking valuation versus the industry set. This is why Wockhardt Share Price News often gets read through both sector and valuation lenses on Univest.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 87.22 | 14.44 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 86.94 | 21.13 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.57 | 4.45 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
Among the supplied peers, Wockhardt’s P/E of 90.04 is above Sun Pharmaceutical Industries at 36.77, Zydus Lifesciences at 26.57, Cipla at 33.49 and Dr. Reddy’s Laboratories at 31.16. It is closer to Divi’s Laboratories at 87.22 and Torrent Pharmaceuticals at 86.94, while remaining below Laurus Labs at 98.88. On P/B, Wockhardt at 7.32 sits above Sun Pharma, Zydus, Cipla, Dr. Reddy’s and even some other large names, but below Divi’s and Torrent. The comparison suggests that Wockhardt Share Price is trading with a higher multiple than several peers.
In profitability terms, Wockhardt’s ROE of 4.29% and ROCE of 6.79% are below the displayed peer set in most cases, including Sun Pharma, Zydus, Cipla, Dr. Reddy’s, Lupin and Torrent. The company’s market cap of Rs 36,827.23 Cr is lower than the large peer names in the set, but still places it in the Large Cap category. For readers checking Wockhardt Stock News, the peer view gives a useful valuation context: the stock’s pricing remains rich relative to several listed pharmaceutical names even after today’s decline. That is a factual comparison, not a forecast.
Why Investors Are Watching Wockhardt
- The share price ended at Rs 2,206.90 after a 2.63% decline from the previous close of Rs 2,266.40.
- The session opened and also printed the day’s high at Rs 2,261.55 before closing at the day’s low of Rs 2,206.90.
- Market capitalisation stands at Rs 36,827.23 Cr, and the company is classified as a Large Cap.
- Valuation metrics show a P/E of 90.04, a P/B of 7.32, EPS of Rs 25.17 and book value of Rs 309.81.
- In the same industry benchmark, Wockhardt’s P/E, P/B, ROE and ROCE can be compared directly with listed healthcare peers.
About Wockhardt
Wockhardt is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile data confirms that it belongs to a broad pharmaceutical universe tracked under the same industry benchmark used in this article. That classification is the relevant business context for Wockhardt Share Price readers today. The stock is tracked on NSE and BSE through Univest’s stock pages, and the same company is covered within the peer set used for valuation comparison. For investors reviewing Wockhardt Company News, the most useful starting point remains the combination of company classification, market capitalisation and reported financial ratios.
Track Wockhardt Share Price on Univest
Use Wockhardt (WOCKPHARMA) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Wockhardt Share Price on Univest for live price updates, stock news, financial ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Wockhardt Share Price Today, valuation ratios, company context and peer comparison in one place for quicker review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Wockhardt share price fall today?
Ans. Wockhardt Share Price fell 2.63% to Rs 2,206.90 today, but the supplied data does not establish a company-specific catalyst. The article reflects the verified price move, session range and valuation context only.
What is Wockhardt share price today?
Ans. Wockhardt Share Price Today is Rs 2,206.90. The stock closed below its previous close of Rs 2,266.40 after moving within a day range from Rs 2,261.55 to Rs 2,206.90. The previous close was Rs 2,266.4.
What is Wockhardt market capitalisation?
Ans. Wockhardt has a market capitalisation of Rs 36,827.23 Cr. That places it in the Large Cap category and helps frame the stock’s current valuation alongside the healthcare peer set. The company operates in the Healthcare sector.
How does Wockhardt compare with healthcare peers?
Ans. Wockhardt’s P/E of 90.04 and P/B of 7.32 are above several listed peers in the supplied set, while its ROE of 4.29% and ROCE of 6.79% are below the benchmark central tendency.
What do Wockhardt valuation metrics show?
Ans. The valuation data shows a P/E of 90.04, P/B of 7.32, EPS of Rs 25.17 and book value of Rs 309.81. Dividend yield is 0, so the supplied payout metric is nil.
Recent Articles

BSE (BSE) Share Price falls 2.42% to Rs 3,114.40; what the data shows today
28 September 2026

CESC Share Price Hits Fresh 52-Week Low at Rs 137: Key Reasons Behind the Fall
28 September 2026

Garden Reach Shipbuilders & Engineers (GRSE): GRSE Share Price Falls 2.49% as Stock Trades at Rs 2,262.45
28 September 2026

Trump Rejects Iran's Peace Proposal: Oil Climbs, the Dollar Firms and Gold Falls as Rate-Hike Bets Build
28 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
BSE (BSE) Share Price falls 2.42% to Rs 3,114.40; what the data shows today
CESC Share Price Hits Fresh 52-Week Low at Rs 137: Key Reasons Behind the Fall
Garden Reach Shipbuilders & Engineers (GRSE): GRSE Share Price Falls 2.49% as Stock Trades at Rs 2,262.45
Trump Rejects Iran's Peace Proposal: Oil Climbs, the Dollar Firms and Gold Falls as Rate-Hike Bets Build
Bank Of Baroda Hits 52-Week Low of Rs 232: What's Dragging the Stock Today
Popular this week
Rupee Opens Near 95.88 With the RBI Guarding 96: What Oil, US Yields and the Dollar Mean for the Currency

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





